Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04498442 · ClinicalTrials.gov registry record · NA

A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls

A NA study of COVID-19 and Stress, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
8,519
Enrollment target
1
Study location

NCT04498442: Completed NA study of COVID-19 and Stress, sponsored by Beth Israel Deaconess Medical Center.

NCT04498442 is a NA study of COVID-19 and Stress that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 8,519 participants, below the 38,436-participant average among 298 other COVID-19 trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04498442, a NA study of COVID-19 and Stress, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
8,519 participants
Enrollment target
1
Study location

Study Summary

The study is a randomized controlled trail with an observational arm and aims at collecting information on the prevalence of COVID 19 infection in seasoned yoga practitioners by comparing it with the prevalence of COVID-19 infection prevalence rates among age and gender matched control participants who do not practice yoga. The study hypothesizes that yoga practice promotes protection and enhances recovery from the COVID-19 infection. To prove the hypothesis, the study investigators are collecting and comparing responses from seasoned yoga practitioners to age and gender matched controls participants (who do not practice yoga routinely) regarding their recovery from the COVID 19 infection. Based on validated questionnaires on perceived stress, anxiety, depression, well-being, mindfulness, joy disposition, and resilience in participants over the study duration, the investigators also collect information on participant's mental and emotional predispositions.

Primary Outcome

The study aims to evaluate changes in perceived levels of stress in survey participants and the effect yoga or reading a book has over them. We use a validated scale for this purpose named, Perceived Stress Scale. The scale measures the degree to which situations in participant's life are appraised as stressful. This is the primary outcome for our study. We assess for change in perceived stress levels by analyzing the PSS score for each participant and comparing it to pre \& post intervention re

Interventions

  • BEHAVIORAL Simha Kriya
  • BEHAVIORAL Reading a Book

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Centre - Boston

Trial Details

FieldValue
Enrollment Target 8,519 participants
Start Date 2020-05-22
Est. Completion 2020-10-22
Phase NA

What the finished NCT04498442 record still lists

NCT04498442 is an interventional study that assigns participants to a tested intervention. Its 8,519 participants enrollment target places it among the larger protocols in the corpus, below the 38,436-participant average among 298 other COVID-19 trials with a reported enrollment target (78% lower).

The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Simha Kriya is the first listed.

NCT04498442 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04498442 about?

NCT04498442 is a clinical study titled "A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls". The study is a randomized controlled trail with an observational arm and aims at collecting information on the prevalence of COVID 19 infection in seasoned yoga practitioners by comparing it with the prevalence of COVID-19 infection prevalence rates among age and gender matched control participants ...

What is the current status of trial NCT04498442?

This trial is currently completed. It is a NA study. The enrollment target is 8,519 participants. The study started on 2020-05-22. Estimated completion is 2020-10-22.

What conditions does trial NCT04498442 study?

This clinical trial studies the following conditions: COVID-19, Stress, Anxiety Depression.

What interventions are being tested in trial NCT04498442?

The interventions under investigation include: Simha Kriya (BEHAVIORAL), Reading a Book (BEHAVIORAL).

Who is sponsoring clinical trial NCT04498442?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04498442 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04498442's enrollment target sits among peer trials

8,519 26th of 298 higher than 273 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06098079 · 8,600 participants · Phase 4

    Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  • NCT06058234 · 8,680 participants

    Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

  • NCT05336877 · 8,744 participants

    Aveir VR Coverage With Evidence Development Post-Approval Study

  • NCT07185828 · 8,286 participants · NA

    Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04498442, the US trial registry maintained by the National Library of Medicine. NCT04498442 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.